Clinical Trial Update: Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas [Phase 1]

View source ↗

Summary

A pediatric Phase 1 trial evaluating selinexor in children with recurrent or refractory solid tumors and high-grade gliomas has completed. Results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma
• Central Nervous System Neoplasms
• Glioblastoma
• Lymphoma
• Malignant Glioma
• Malignant Solid Neoplasms

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Children's Oncology Group | Conditions: Malignant Glioma, Recurrent Brain Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2024-01-02